dc.contributor.author | Mert, Kadir Ugur | |
dc.contributor.author | Mert, Gurbet Ozge | |
dc.contributor.author | Başaran, Özcan | |
dc.contributor.author | Biteker, Murat | |
dc.date.accessioned | 2020-11-20T16:17:42Z | |
dc.date.available | 2020-11-20T16:17:42Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0167-5273 | |
dc.identifier.issn | 1874-1754 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijcard.2014.10.021 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/3332 | |
dc.description | BASARAN, OZCAN/0000-0002-6384-6455; Mert, Kadir Ugur/0000-0002-1331-5365; | en_US |
dc.description | WOS: 000345232200134 | en_US |
dc.description | PubMed ID: 25456579 | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Ivabradine | en_US |
dc.subject | Dobutamine | en_US |
dc.subject | Heart Failure | en_US |
dc.subject | Heart Rate | en_US |
dc.title | Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: Parallax in significance | en_US |
dc.item-type | letter | en_US |
dc.contributor.department | MÜ | en_US |
dc.contributor.departmentTemp | [Mert, Kadir Ugur; Mert, Gurbet Ozge; Basaran, Ozcan; Biteker, Murat] Mugla Sitki Kocman Univ, Fac Med, Dept Cardiol, Mugla, Turkey | en_US |
dc.identifier.doi | 10.1016/j.ijcard.2014.10.021 | |
dc.identifier.volume | 177 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 726 | en_US |
dc.identifier.endpage | 726 | en_US |
dc.relation.journal | International Journal of Cardiology | en_US |
dc.relation.publicationcategory | Diğer | en_US |